Join host Jason Foster in a fascinating conversation with Volodimir Olexiouk, Director of Scientific Engagement at BioLizard. Together, they delve into the revolutionary intersection of artificial intelligence and pharmaceuticals, exploring how AI is transforming the landscape of drug discovery.
Tune in now and gain insights into the innovative ways AI is transforming drug discovery and shaping the future of healthcare and biotechnology.
Listen to this episode on Spotify, iTunes, and Stitcher. You can also catch up on the previous episodes of the Hub & Spoken podcast when you subscribe.
What are your thoughts on this topic? We’d love to hear from you; join the discussion and let us know on LinkedIn.
___
Check out our free AI Scorecard and we’ll send you a personalised report that outlines what’s needed to drive innovation to your business and be competitive.
with Volodimir Olexiouk, Director of Scientific Engagement at BioLizard
listen
with Brian Paull, Chief Data & Analytics Officer at First Citizens Bank
listen
with Bart Vandenreijt, Chief Data & Analytics Officer at Partenamut
listen
with Steve Janoo, Chief Data Officer for Diageo
listen
with Gareth Powell, Group Data Officer and Partner at Irwin Mitchell
listen
Ibrahim Gokcen, Chief Data and Analytics Officer at Aon
listen
with Tara Halliday, esteemed expert on Imposter Syndrome
listen
with Olivia Duane Adams and Jason Belland
listen
with Danette McGilvray
listen